| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Palbociclib impurity 13 |
帕布昔利布雜質(zhì)13 |
1651214-74-2 |
詳細
|
| Palbociclib impurity 11 |
帕布昔利布雜質(zhì)11 |
2206135-30-8 |
詳細
|
| Palbociclib impurity 07 |
帕布昔利布雜質(zhì)07 |
827022-35-5 |
詳細
|
| Rosuvastatin calcium impurity J |
瑞舒伐他汀鈣EP-ZJ |
2226413-62-1 |
詳細
|
| Palbociclib impurity 10 |
帕布昔利布雜質(zhì)10 |
2204863-06-7 |
詳細
|
| Palbociclib impurity 09 |
帕布昔利布雜質(zhì)09 |
1922954-32-2 |
詳細
|
| Palbociclib impurity 54 |
帕布昔利布雜質(zhì)54 |
1082876-26-3 |
詳細
|
| Palbociclib impurity 02 |
帕布昔利布雜質(zhì)02 |
571191-15-6 |
詳細
|
| Palbociclib impurity 12 |
帕布昔利布雜質(zhì)12 |
2174002-29-8 |
詳細
|
| Palbociclib impurity 03 |
帕布昔利布雜質(zhì)03 |
2324831-15-2 |
詳細
|
| Palbociclib impurity01; 6-acetyl-8-cyclopentyl-2-((5-(ethylamino)pyridin-2-yl)amino)-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
帕布昔利布雜質(zhì)01 |
|
詳細
|
| Letrozole impurity 07 |
來曲唑雜質(zhì)07 |
2451658-74-3 |
詳細
|
| Letrozole impurity 08; 1-(bis(4-cyanophenyl)methyl)-1H-1,2,4-triazole 4-oxide |
來曲唑雜質(zhì)08 |
|
詳細
|
| Rosuvastatin calcium impurity A |
瑞舒伐他汀鈣EP-ZA |
1715120-13-0 |
詳細
|
| Rosuvastatin calcium impurity B |
瑞舒伐他汀鈣EP-ZB |
1094100-06-7 |
詳細
|
| Levetiracetam impurity 10; diethyl 4,4'-((1-methoxy-1-oxobutan-2-yl)azanediyl)dibutyrate |
左乙拉西坦雜質(zhì)雜質(zhì)10 |
|
詳細
|
| Levetiracetam impurity 11 |
左乙拉西坦雜質(zhì)雜質(zhì)11 |
93778-15-5 |
詳細
|
| Rosuvastatin calcium impurity D |
瑞舒伐他汀鈣EP-ZD |
1422954-11-7 |
詳細
|
| Rosuvastatin calcium impurity F |
瑞舒伐他汀鈣EP-ZF |
289042-12-2 |
詳細
|
| Rosuvastatin calcium impurity C |
瑞舒伐他汀鈣EP-ZC |
1422619-13-3 |
詳細
|
| Levetiracetam impurity C |
左乙拉西坦雜質(zhì)雜質(zhì)EP-ZC |
3886-69-9 |
詳細
|
| Levetiracetam impurity 04 |
左乙拉西坦雜質(zhì)雜質(zhì)04 |
102767-31-7 |
詳細
|
| Levetiracetam impurity 05 |
左乙拉西坦雜質(zhì)雜質(zhì)05 |
1342229-32-6 |
詳細
|
| Phenylephrine impurity D |
苯腎上腺素雜質(zhì)04 |
636-87-3 |
詳細
|
| Phenylephrine impurity H |
苯腎上腺素雜質(zhì)08 |
1477-63-0 |
詳細
|
| Levetiracetam impurity 06 |
左乙拉西坦雜質(zhì)雜質(zhì)06 |
1543353-92-9 |
詳細
|
| Phenylephrine impurity E |
苯腎上腺素雜質(zhì)05 |
38396-89-3 |
詳細
|
| Levetiracetam impurity 07 |
左乙拉西坦雜質(zhì)雜質(zhì)07 |
429673-89-2 |
詳細
|
| Levetiracetam impurity A |
左乙拉西坦雜質(zhì)雜質(zhì)EP-ZA |
67118-31-4 |
詳細
|
| Phenylephrine impurity G |
苯腎上腺素雜質(zhì)07 |
939-38-8 |
詳細
|
| Levetiracetam impurity 09 |
左乙拉西坦雜質(zhì)雜質(zhì)09 |
1868118-63-1 |
詳細
|
| N-formyl Vortioxetine |
沃替西汀雜質(zhì)A |
2135576-73-5 |
詳細
|
| Vortioxetine Sulfone |
沃替西汀雜質(zhì)D |
1639263-80-1 |
詳細
|
| N-Methyl Vortioxetine Hydrobromide |
沃替西汀雜質(zhì)B |
1293489-87-8 |
詳細
|
| N-Acetyl Vortioxetine |
沃替西汀雜質(zhì)F |
1801352-86-2 |
詳細
|
| Axitinib impurity E |
阿西替尼雜質(zhì)E |
885126-34-1 |
詳細
|
| Axitinib impurity I |
阿西替尼雜質(zhì)I |
1348536-59-3 |
詳細
|
| Axitinib impurity D |
阿西替尼雜質(zhì)D |
944835-85-2 |
詳細
|
| Axitinib impurity H |
阿西替尼雜質(zhì)H |
1443118-73-7 |
詳細
|
| Axitinib impurity F |
阿西替尼雜質(zhì)F |
885126-40-9 |
詳細
|
| Axitinib impurity C |
阿西替尼雜質(zhì)C |
1959572-98-5 |
詳細
|
| Axitinib impurity A |
阿西替尼雜質(zhì)A |
1959572-97-4 |
詳細
|
| Axitinib impurity G |
阿西替尼雜質(zhì)G |
1428728-83-9 |
詳細
|
| Fluticasone furoate impurity EP-ZL; [6α,9-Difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17-yl][6α,9-difluoro-17α-[(furan-2-ylcarbonyl)oxy]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17-yl]dithioperoxyanhydride |
糠酸氟替卡松雜質(zhì)EP-ZL |
|
詳細
|
| Fluticasone furoate impurity EP-ZJ; 6α,9-Difluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl 5-chlorofuran-2-carboxylate |
糠酸氟替卡松雜質(zhì)EP-ZJ |
|
詳細
|
| Fluticasone Furoate 1,2 Dihydro Sulfenic Acid |
糠酸氟替卡松雜質(zhì)-13 |
948566-11-8 |
詳細
|
| Olanzapine impurity C |
奧氮平EP-ZC |
719300-59-1 |
詳細
|
| Olanzapine impurity E |
奧氮平EP雜質(zhì)5 |
161696-76-0 |
詳細
|
| Olanzapine impurity D |
奧氮平EP-ZD |
174794-02-6 |
詳細
|
| Phenylephrine impurity C |
苯腎上腺素雜質(zhì)03 |
1159977-09-9 |
詳細
|
| Olanzapine impurity G |
奧氮平EP雜質(zhì)7 |
1070876-09-3 |
詳細
|
| Olanzapine impurity H |
奧氮平EP雜質(zhì)8 |
935272-10-9 |
詳細
|
| Phenylephrine impurity B |
苯腎上腺素雜質(zhì)02 |
94240-17-2 |
詳細
|
| Phenylephrine impurity A |
苯腎上腺素雜質(zhì)01 |
71786-67-9 |
詳細
|
| Desonide 21-Acetate |
布地奈德EP-ZM |
25092-25-5 |
詳細
|
| Olanzapine impurity B |
奧氮平EP-ZB |
221176-49-4 |
詳細
|
| Budesonide impurity B |
布地奈德EP-ZB |
1040085-98-0 |
詳細
|
| Olanzapine impurity A |
奧氮平EP-ZA |
138564-59-7 |
詳細
|
| Budesonide impurity J |
布地奈德EP-ZJ |
313474-59-8 |
詳細
|
| Budesonide impurity H |
布地奈德EP-ZH |
313474-58-7 |
詳細
|
| Budesonide impurity A |
布地奈德EP-ZA |
13951-70-7 |
詳細
|
| Budesonide impurity I |
布地奈德EP-ZI |
113930-13-5 |
詳細
|
| Budesonide impurity L |
布地奈德EP-ZL |
216453-74-6 |
詳細
|
| Budesonide impurity K |
布地奈德EP-ZK |
51333-05-2 |
詳細
|
| Fluticasone Trioxo Impurity |
布地奈德EP-ZN |
5541-37-7 |
詳細
|
| Budesonide impurity F |
布地奈德EP-ZF |
638-94-8 |
詳細
|
| Budesonide impurity G |
布地奈德EP-ZG |
137174-25-5 |
詳細
|
| Budesonide impurity D |
布地奈德EP-ZD |
85234-63-5 |
詳細
|
| Olanzapine impurity F |
奧氮平EP雜質(zhì)6 |
138564-60-0 |
詳細
|
| Budesonide impurity E |
布地奈德EP-ZE |
131918-64-4 |
詳細
|
| Budesonide impurity C |
布地奈德EP-ZC |
1040085-99-1 |
詳細
|
| fluticasone propionate impurity EP-ZF |
丙酸氟替卡松雜質(zhì)F |
1219174-94-3 |
詳細
|
| fluticasone propionate impurity EP-ZB |
丙酸氟替卡松雜質(zhì)B |
948566-12-9 |
詳細
|
| Fluticasone furoate impurity EP-ZB |
糠酸氟替卡松雜質(zhì)EP-ZB |
80474-24-4 |
詳細
|
| fluticasone propionate impurity EP-ZE |
丙酸氟替卡松雜質(zhì)E |
105613-90-9 |
詳細
|
| fluticasone propionate impurity EP-ZA |
丙酸氟替卡松雜質(zhì)A |
65429-42-7 |
詳細
|
| fluticasone propionate impurity EP-ZD |
丙酸氟替卡松雜質(zhì)D |
73205-13-7 |
詳細
|
| Fluticasone furoate impurity EP-ZG |
糠酸氟替卡松雜質(zhì)EP-ZG |
785806-96-4 |
詳細
|
| Fluticasone furoate impurity EP-ZE |
糠酸氟替卡松雜質(zhì)EP-ZE |
398454-97-2 |
詳細
|
| Fluticasone furoate impurity EP-ZA |
糠酸氟替卡松雜質(zhì)EP-ZA |
397864-63-0 |
詳細
|
| Chloro Fluticasone Propionate |
丙酸氟替卡松雜質(zhì)10 |
80486-69-7 |
詳細
|
| Fluticasone Trioxo Impurity |
丙酸氟替卡松雜質(zhì)11 |
219719-95-6 |
詳細
|
| fluticasone propionate impurity EP-ZH |
丙酸氟替卡松雜質(zhì)H |
201812-64-8 |
詳細
|
| Fluticasone propionate impurity EP-ZG |
丙酸氟替卡松雜質(zhì)G |
220589-37-7 |
詳細
|
| Fluticasone furoate impurity EP-ZI |
糠酸氟替卡松雜質(zhì)EP-ZI |
948569-98-0 |
詳細
|
| Fluticasone furoate impurity EP-ZF; Propan-2-yl 6α,9-difluoro-17α-[(furan-2-ylcarbonyl)oxy]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17-carboxylate |
糠酸氟替卡松雜質(zhì)EP-ZF |
|
詳細
|
| 11-Oxo-Fluticasone Furoate |
糠酸氟替卡松雜質(zhì)-12 |
397864-57-2 |
詳細
|
| Chloro Fluticasone Furoate |
糠酸氟替卡松雜質(zhì)-11 |
1374153-88-4 |
詳細
|
| 3-Bromo-vortioxetine Hydrobromide |
沃替西汀雜質(zhì)C |
2725536-51-4 |
詳細
|
| 1,4-Bis[2-[(2,4-dimethylphenyl)thio]phenyl]piperazine |
沃替西汀雜質(zhì)G |
2243045-82-9 |
詳細
|
| Rosuvastatin calcium impurity E |
瑞舒伐他汀鈣EP-ZE |
2226413-61-0 |
詳細
|
| Letrozole impurity 05 |
來曲唑雜質(zhì)05 |
2500927-47-7 |
詳細
|
| fluticasone propionate impurity EP-ZI |
丙酸氟替卡松雜質(zhì)I |
960071-64-1 |
詳細
|
| Fluticasone Furoate Trisulphane |
糠酸氟替卡松雜-14 |
|
詳細
|
| Desethylene Vortioxetine |
沃替西汀雜質(zhì)E |
2831955-36-1 |
詳細
|
| Phenylephrine impurity F; 3-(2,2-dibromoacetyl)phenyl acetate |
苯腎上腺素雜質(zhì)06 |
|
詳細
|
| Levetiracetam impurity 08 |
左乙拉西坦雜質(zhì)雜質(zhì)08 |
81107-75-7 |
詳細
|
| Fluticasone furoate impurity EP-ZH; 6α-Chloro-9-fluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl furan-2-carboxylate |
糠酸氟替卡松雜質(zhì)EP-ZH |
|
詳細
|
| 3-[(2,4-Dimethylphenyl)thio]benzenamine |
沃替西汀雜質(zhì)K |
1184281-83-1 |
詳細
|
| Axitinib impurity B |
阿西替尼雜質(zhì)B |
1443118-71-5 |
詳細
|